SIEMENS HEALTH ADR/050 (F:SHL1) — Market Cap & Net Worth
Market Cap & Net Worth: SIEMENS HEALTH ADR/050 (SHL1)
SIEMENS HEALTH ADR/050 (F:SHL1) has a market capitalization of $46.68 Billion (€39.93 Billion) as of May 2, 2026. Listed on the F stock exchange, this Germany-based company holds position #558 globally and #119 in its home market, demonstrating a -9.64% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SIEMENS HEALTH ADR/050's stock price €17.80 by its total outstanding shares 2243111308 (2.24 Billion).
SIEMENS HEALTH ADR/050 Market Cap History: 2018 to 2026
SIEMENS HEALTH ADR/050's market capitalization history from 2018 to 2026. Data shows growth from $41.12 Billion to $46.68 Billion (0.71% CAGR).
SIEMENS HEALTH ADR/050 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SIEMENS HEALTH ADR/050's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SHL1 by Market Capitalization
Companies near SIEMENS HEALTH ADR/050 in the global market cap rankings as of May 2, 2026.
Key companies related to SIEMENS HEALTH ADR/050 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
SIEMENS HEALTH ADR/050 Historical Marketcap From 2018 to 2026
Between 2018 and today, SIEMENS HEALTH ADR/050's market cap moved from $41.12 Billion to $ 46.68 Billion, with a yearly change of 0.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €46.68 Billion | -18.35% |
| 2025 | €57.17 Billion | -13.49% |
| 2024 | €66.09 Billion | -1.85% |
| 2023 | €67.33 Billion | +12.34% |
| 2022 | €59.93 Billion | -24.75% |
| 2021 | €79.65 Billion | +61.00% |
| 2020 | €49.47 Billion | -1.71% |
| 2019 | €50.34 Billion | +22.40% |
| 2018 | €41.12 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of SIEMENS HEALTH ADR/050 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $46.68 Billion USD |
| MoneyControl | $46.68 Billion USD |
| MarketWatch | $46.68 Billion USD |
| marketcap.company | $46.68 Billion USD |
| Reuters | $46.68 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SIEMENS HEALTH ADR/050
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound sys… Read more